We've noticed that you're using an ad blocker

Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.

It's off now Dismiss How do I disable my ad blocker?
❌

How to disable your ad blocker for our site:

Adblock / Adblock Plus
  • Click on the AdBlock / AdBlock Plus icon on the top right of your browser.
  • Click “Don’t run on pages on this domain.” OR “Enabled on this site.”
  • Close this help box and click "It's off now".
Firefox Tracking Prevention
  • If you are Private Browsing in Firefox, "Tracking Protection" may casue the adblock notice to show. It can be temporarily disabled by clicking the "shield" icon in the address bar.
  • Close this help box and click "It's off now".
Ghostery
  • Click the Ghostery icon on your browser.
  • In Ghostery versions < 6.0 click “Whitelist site.” in version 6.0 click “Trust site.”
  • Close this help box and click "It's off now".
uBlock / uBlock Origin
  • Click the uBlock / uBlock Origin icon on your browser.
  • Click the “power” button in the menu that appears to whitelist the current website
  • Close this help box and click "It's off now".
  • ONCOLOGY
  • News
  • Blogs
  • Topics
  • Hematology
  • Image IQ
  • Podcasts
  • Videos
  • Slideshows
  • Conferences

Modern Medicine Network
  • Login
  • Register
Skip to main content
Modern Medicine Network
  • Login
  • Register
Menu
User
Home
  • ONCOLOGY
  • News
  • Blogs
  • Topics
  • Hematology
  • Image IQ
  • Podcasts
  • Videos
  • Slideshows
  • Conferences

SUBSCRIBE: Print / eNewsletter

NCCN Unveils Preliminary Guidelines

Mar 1, 1996
Volume: 
5
Issue: 
3

FORT LAUDERDALE, Fla--The National Comprehensive Cancer Network
(NCCN) unveiled preliminary clinical practice guidelines for eight
diseases at its first annual conference (see photograph below).
The network now includes 14 institutions nationwide with the addition
of its newest member, Roswell Park Cancer Institute.

In an interview, Stanford University's Robert Carlson, MD, chair
of the breast cancer panel, said that "there was remarkable
agreement among our committee in nearly all aspects of the guidelines."
He cited two primary areas of controversy.

In the committee's initial draft, routine chest x-rays were not
included in the follow-up of patients after adjuvant chemotherapy.
"However, there was a ground swell from people external to
the committee that made it clear to us that the guidelines had
to include routine surveillance chest x-rays."

The other topic of greatest discussion was whether to include
high-dose intensive chemotherapy with bone marrow/stem cell support
in the guidelines as a routine treatment, an issue that pitted
what Dr. Carlson called "disease-oriented specialists"
against "modality-oriented specialists."

"The committee felt, without exception, that high-dose intensive
therapy was investigational," he said. Consequently, in a
footnote to the breast cancer guidelines, the committee stated
that "based on current evidence and NCCN expertise, dose-intensive
chemotherapy is not appropriate outside the confines of an appropriately
designed, peer-reviewed prospective clinical trial." Peer
review in this context includes formal NCI review or NCCN institutional
sci,entific review committees.

Dr. Carlson called the footnote "a positive statement signifying
that we need more information regarding high-dose intense therapy;
we certainly encourage participation in clinical trials."

At the meeting, Dr. Carlson asked the audience for a show of hands
as to whether dose-intensive chemotherapy should be restricted
to clinical trials or included in the guidelines for use in high-risk
patients (10 or more positive nodes) or patients with responding
metastatic disease in first relapse.

Pages

  • 1
  • 2
  • 3
  • next ›
  • last »

Resource Topics rightRail

  • Resource Topics
  • Partner Content
Breast Cancer
Lung Cancer
Prostate Cancer
Colorectal Cancer
Melanoma
Cutaneous T-Cell Lymphomas: Mycosis Fungoides and Sézary Syndrome
3 Keys to Success in the Oncology Care Model

Current Issue

Oncology Vol 32 No 4
Apr 15, 2018 Vol 32 No 4
Digital Edition
Subscribe
Connect with Us
  • Twitter
  • Facebook
  • LinkedIn
  • RSS
Modern Medicine Network
  • Home
  • About Us
  • Advertise
  • Advertiser Terms
  • Privacy statement
  • Terms & Conditions
  • Editorial & Advertising Policy
  • Editorial Board
  • Contact Us
Modern Medicine Network
© UBM 2018, All rights reserved.
Reproduction in whole or in part is prohibited.